Financials
Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -26035.7% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | 0.0 |
PEG | n/a | n/a |
Pr/Revenue | 1299.7 | n/a |
Pr/Book | 0.6 |
Latest | F'cast | |
---|---|---|
Revenue | 3163.4% | -100.0% |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-18 | 51.17 | 42.76 | 32.10p | 5.2 | n/a | n/a | n/a | 0.0% |
31-Dec-19 | 0.51 | (75.57) | (53.80)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | 0.48 | 126.30 | 96.60p | 2.3 | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 0.34 | (61.08) | (0.48)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 0.11 | (27.58) | (23.90)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-23 | n/a | n/a | 18,815.50p | 0.0 | n/a | n/a | n/a | 0.0% |
Copyright © 2023 FactSet Research Systems Inc. All rights reserved.
Correction: Portfolio Company Aura Biosciences A... | 13-Nov-2023 | 16:00 | EQS Group |
Portfolio Company Aura Biosciences Announces Clo... | 10-Nov-2023 | 08:00 | EQS Group |
PDMR Notification & Director Shareholding | 10-Nov-2023 | 07:00 | EQS Group |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
09-Nov-23 | Buy | Andrew Smith | 113.00p | 25,000 | £28,250.00 |
03-Nov-23 | Buy | Peregrine D E M Moncreiffe | 115.00p | 40,000 | £46,000.00 |
02-Nov-23 | Buy | Peregrine D E M Moncreiffe | 114.69p | 60,000 | £68,814.00 |
Currency | UK Pounds |
Share Price | 112.50p |
Change Today | -1.00p |
% Change | -0.88 % |
52 Week High | 125.00p |
52 Week Low | 97.00p |
Volume | 17,090 |
Shares Issued | 129.39m |
Market Cap | £145.56m |
Beta | 0.32 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 0 |
Buy | 0 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
16:35 | 15 @ 112.50p |
16:35 | 15 @ 112.50p |
14:01 | 1,000 @ 112.15p |
14:00 | 5,000 @ 112.50p |
14:00 | 5,000 @ 112.50p |
Chair | Peregrine D E M Moncreiffe |
CEO | Robert Lyne |
You are here: research